Nebulized 3% hypertonic saline in the treatment of acute bronchiolitis in infants Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Effectiveness of nebulised hypertonic saline on the respiratory management of children and young people with neuromuscular disease Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019
Clinical surveys with nebulised hypertonic saline (HS) in CF children Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020
Combination therapy of ICSs/LABAs plus montelucastin patients with severe asthma Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015
Once-daily inhaled corticosteroids in children with asthma: Not a simple solution for non-adherence Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013
L-carnitine improves the asthma control in children with moderate persistent asthma Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013
Safety and efficacy of 7% hypertonic saline in patients with bronchiectasis Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013
Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010
E-monitoring of asthma therapy to improve compliance in children (E-MATIC) Source: International Congress 2015 – Paediatric asthma and allergy: e-health in management Year: 2015
A single blind study to compare nebulised hypertonic saline (7%) and normal saline (0.9%) as an adjunct to physiotherapy airway clearance in patients with bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 304s Year: 2005
Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013
Tracheostomy in children: A single center outcome results Source: International Congress 2016 – Paediatric bronchology II Year: 2016
Safety of tiotropium Respimat® add-on therapy in patients aged 6-17 years with symptomatic asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Wet cough in paediatric severe therapy resistant asthma (STRA) Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016
Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021
Magnesium deficiency correction for improvement of children bronchial asthma treatment results Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015
Achievement of asthma control in patients with cold airway hyperresponsiveness at different variants of basic therapy Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013
The effect of treatment duration by inhaled glucocorticosteroids, on “cough variant asthma” in children Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013
Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5 Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016